Pulmonary vascular disease--overview.
Some intriguing advances in the diagnosis of pulmonary vascular diseases have been made in the past decade. Moreover, developments in treatment of recurrent thromboembolic disease have come to the forefront, with a considerable reduction in morbidity and mortality rates in the past few years.
D000792:Angiography; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008168:Lung / Q000000981:diagnostic imaging; D008173:Lung Diseases, Obstructive / Q000000981:diagnostic imaging / Q000628:therapy; D008203:Lymphangiomyoma / Q000188:drug therapy; D008525:Medroxyprogesterone / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010690:Phlebography; D011651:Pulmonary Artery; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy; D011877:Radionuclide Imaging; D013726:Terbutaline / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000175:diagnosis; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D006830:Hydralazine; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator; D008525:Medroxyprogesterone; D013726:Terbutaline